nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2A6—esophageal cancer	0.752	1	CbGaD
Flunitrazepam—CYP2C9—Capecitabine—esophageal cancer	0.00955	0.407	CbGbCtD
Flunitrazepam—CYP2B6—Cisplatin—esophageal cancer	0.0091	0.388	CbGbCtD
Flunitrazepam—CYP2C9—Cisplatin—esophageal cancer	0.00481	0.205	CbGbCtD
Flunitrazepam—TSPO—exocrine gland—esophageal cancer	0.000983	0.104	CbGeAlD
Flunitrazepam—UGT1A3—digestive system—esophageal cancer	0.000966	0.102	CbGeAlD
Flunitrazepam—GABRA3—neck—esophageal cancer	0.000912	0.0967	CbGeAlD
Flunitrazepam—TSPO—neck—esophageal cancer	0.000628	0.0667	CbGeAlD
Flunitrazepam—UGT2B7—digestive system—esophageal cancer	0.000555	0.0589	CbGeAlD
Flunitrazepam—UGT1A1—digestive system—esophageal cancer	0.000472	0.05	CbGeAlD
Flunitrazepam—TSPO—epithelium—esophageal cancer	0.000428	0.0454	CbGeAlD
Flunitrazepam—TSPO—bronchus—esophageal cancer	0.000421	0.0447	CbGeAlD
Flunitrazepam—TSPO—smooth muscle tissue—esophageal cancer	0.000412	0.0437	CbGeAlD
Flunitrazepam—TSPO—trachea—esophageal cancer	0.000378	0.0401	CbGeAlD
Flunitrazepam—CYP2A6—lung—esophageal cancer	0.000332	0.0352	CbGeAlD
Flunitrazepam—TSPO—digestive system—esophageal cancer	0.000325	0.0345	CbGeAlD
Flunitrazepam—TSPO—lung—esophageal cancer	0.000272	0.0288	CbGeAlD
Flunitrazepam—CYP2B6—bronchus—esophageal cancer	0.000259	0.0275	CbGeAlD
Flunitrazepam—CYP2C19—digestive system—esophageal cancer	0.000256	0.0271	CbGeAlD
Flunitrazepam—Flurazepam—CYP2A6—esophageal cancer	0.000237	0.235	CrCbGaD
Flunitrazepam—CYP1A2—digestive system—esophageal cancer	0.000209	0.0222	CbGeAlD
Flunitrazepam—GABRA2—lymph node—esophageal cancer	0.000201	0.0213	CbGeAlD
Flunitrazepam—CYP2B6—digestive system—esophageal cancer	0.0002	0.0212	CbGeAlD
Flunitrazepam—CYP2C9—digestive system—esophageal cancer	0.000198	0.021	CbGeAlD
Flunitrazepam—CYP2E1—digestive system—esophageal cancer	0.000188	0.0199	CbGeAlD
Flunitrazepam—TSPO—lymph node—esophageal cancer	0.000186	0.0197	CbGeAlD
Flunitrazepam—CYP1A2—lung—esophageal cancer	0.000174	0.0185	CbGeAlD
Flunitrazepam—Ketazolam—ABCB1—esophageal cancer	0.00017	0.168	CrCbGaD
Flunitrazepam—CYP2B6—lung—esophageal cancer	0.000167	0.0177	CbGeAlD
Flunitrazepam—CYP2E1—lung—esophageal cancer	0.000157	0.0166	CbGeAlD
Flunitrazepam—CYP3A4—digestive system—esophageal cancer	0.000151	0.016	CbGeAlD
Flunitrazepam—Diazepam—PTGS1—esophageal cancer	0.000144	0.143	CrCbGaD
Flunitrazepam—Clobazam—ABCB1—esophageal cancer	0.00012	0.119	CrCbGaD
Flunitrazepam—Nitrazepam—ABCB1—esophageal cancer	9.94e-05	0.0982	CrCbGaD
Flunitrazepam—Flurazepam—ABCB1—esophageal cancer	8.84e-05	0.0873	CrCbGaD
Flunitrazepam—Midazolam—ABCB1—esophageal cancer	8.19e-05	0.0809	CrCbGaD
Flunitrazepam—Slurred speech—Cisplatin—esophageal cancer	7.46e-05	0.0885	CcSEcCtD
Flunitrazepam—Diazepam—ABCB1—esophageal cancer	7.02e-05	0.0694	CrCbGaD
Flunitrazepam—Balance disorder—Capecitabine—esophageal cancer	4.5e-05	0.0533	CcSEcCtD
Flunitrazepam—Dysarthria—Cisplatin—esophageal cancer	3.53e-05	0.0418	CcSEcCtD
Flunitrazepam—UGT1A1—Metabolism—CYP2A6—esophageal cancer	3.41e-05	0.00016	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP1B1—esophageal cancer	3.38e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.34e-05	0.000157	CbGpPWpGaD
Flunitrazepam—Hiccups—Cisplatin—esophageal cancer	3.34e-05	0.0396	CcSEcCtD
Flunitrazepam—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.29e-05	0.000154	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—ABCB1—esophageal cancer	3.27e-05	0.000154	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CA1—esophageal cancer	3.24e-05	0.000152	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.24e-05	0.000152	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ENO1—esophageal cancer	3.23e-05	0.000152	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS1—esophageal cancer	3.23e-05	0.000152	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ADH1B—esophageal cancer	3.2e-05	0.00015	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PSME1—esophageal cancer	3.18e-05	0.00015	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PSME2—esophageal cancer	3.18e-05	0.00015	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP19A1—esophageal cancer	3.18e-05	0.000149	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GAPDH—esophageal cancer	3.16e-05	0.000149	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CRABP1—esophageal cancer	3.14e-05	0.000147	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ADH1B—esophageal cancer	3.13e-05	0.000147	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.11e-05	0.000146	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TYMP—esophageal cancer	3.06e-05	0.000144	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TYMP—esophageal cancer	3e-05	0.000141	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GNG7—esophageal cancer	2.98e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP26A1—esophageal cancer	2.98e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC52A3—esophageal cancer	2.97e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BLVRB—esophageal cancer	2.97e-05	0.00014	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CA2—esophageal cancer	2.97e-05	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.96e-05	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CA1—esophageal cancer	2.96e-05	0.000139	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.95e-05	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP26A1—esophageal cancer	2.91e-05	0.000137	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—HMOX1—esophageal cancer	2.9e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.9e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALOX15—esophageal cancer	2.9e-05	0.000136	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALOX15—esophageal cancer	2.84e-05	0.000133	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALDH2—esophageal cancer	2.79e-05	0.000131	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ABCB1—esophageal cancer	2.78e-05	0.000131	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTO1—esophageal cancer	2.77e-05	0.00013	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TPI1—esophageal cancer	2.77e-05	0.00013	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PLCE1—esophageal cancer	2.76e-05	0.00013	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADH7—esophageal cancer	2.76e-05	0.00013	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP1B1—esophageal cancer	2.75e-05	0.000129	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.73e-05	0.000128	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTO1—esophageal cancer	2.71e-05	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TPI1—esophageal cancer	2.71e-05	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CA2—esophageal cancer	2.71e-05	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTT1—esophageal cancer	2.66e-05	0.000125	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.66e-05	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALDOB—esophageal cancer	2.65e-05	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.64e-05	0.000124	CbGpPWpGaD
Flunitrazepam—Dysarthria—Capecitabine—esophageal cancer	2.6e-05	0.0308	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—ALDOB—esophageal cancer	2.6e-05	0.000122	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP19A1—esophageal cancer	2.58e-05	0.000121	CbGpPWpGaD
Flunitrazepam—Amnesia—Cisplatin—esophageal cancer	2.58e-05	0.0306	CcSEcCtD
Flunitrazepam—CYP2B6—Metabolism—GAPDH—esophageal cancer	2.55e-05	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CRABP1—esophageal cancer	2.53e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CA1—esophageal cancer	2.53e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.53e-05	0.000119	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.51e-05	0.000118	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADH7—esophageal cancer	2.51e-05	0.000118	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GAPDH—esophageal cancer	2.5e-05	0.000118	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ENO1—esophageal cancer	2.49e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.49e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.49e-05	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CRABP1—esophageal cancer	2.48e-05	0.000116	CbGpPWpGaD
Flunitrazepam—Hiccups—Capecitabine—esophageal cancer	2.46e-05	0.0292	CcSEcCtD
Flunitrazepam—CYP2A6—Metabolism—PSME2—esophageal cancer	2.45e-05	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PSME1—esophageal cancer	2.45e-05	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.42e-05	0.000114	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GNG7—esophageal cancer	2.41e-05	0.000113	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—HMOX1—esophageal cancer	2.36e-05	0.000111	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GNG7—esophageal cancer	2.36e-05	0.000111	CbGpPWpGaD
Flunitrazepam—Irritability—Cisplatin—esophageal cancer	2.31e-05	0.0274	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—CA2—esophageal cancer	2.31e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TYMP—esophageal cancer	2.31e-05	0.000109	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.29e-05	0.000108	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.29e-05	0.000108	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ABCB1—esophageal cancer	2.26e-05	0.000106	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.26e-05	0.000106	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.25e-05	0.000106	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.25e-05	0.000106	CbGpPWpGaD
Flunitrazepam—Orthostatic hypotension—Cisplatin—esophageal cancer	2.21e-05	0.0262	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—ALDH2—esophageal cancer	2.21e-05	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.21e-05	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.19e-05	0.000103	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CREBBP—esophageal cancer	2.19e-05	0.000103	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.15e-05	0.000101	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADH7—esophageal cancer	2.15e-05	0.000101	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000101	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.12e-05	9.98e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2.12e-05	9.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2.12e-05	9.95e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TYMP—esophageal cancer	2.11e-05	9.91e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTT1—esophageal cancer	2.1e-05	9.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TPI1—esophageal cancer	2.09e-05	9.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.09e-05	9.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP2A6—esophageal cancer	2.08e-05	9.76e-05	CbGpPWpGaD
Flunitrazepam—Sleep disorder—Capecitabine—esophageal cancer	2.06e-05	0.0245	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.05e-05	9.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ENO1—esophageal cancer	2.01e-05	9.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.01e-05	9.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALDOB—esophageal cancer	2e-05	9.42e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALOX15—esophageal cancer	2e-05	9.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.99e-05	9.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PSME2—esophageal cancer	1.98e-05	9.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PSME1—esophageal cancer	1.98e-05	9.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ENO1—esophageal cancer	1.97e-05	9.25e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.97e-05	9.25e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—NOS3—esophageal cancer	1.96e-05	9.21e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.95e-05	9.17e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CA1—esophageal cancer	1.95e-05	9.17e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PSME2—esophageal cancer	1.94e-05	9.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PSME1—esophageal cancer	1.94e-05	9.12e-05	CbGpPWpGaD
Flunitrazepam—Dysarthria—Methotrexate—esophageal cancer	1.94e-05	0.023	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.93e-05	9.07e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.91e-05	8.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.91e-05	8.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TPI1—esophageal cancer	1.91e-05	8.96e-05	CbGpPWpGaD
Flunitrazepam—Amnesia—Capecitabine—esophageal cancer	1.9e-05	0.0225	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.88e-05	8.86e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CREBBP—esophageal cancer	1.86e-05	8.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.83e-05	8.59e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GNG7—esophageal cancer	1.82e-05	8.55e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.82e-05	8.54e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TYMP—esophageal cancer	1.8e-05	8.46e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—esophageal cancer	1.79e-05	8.42e-05	CbGpPWpGaD
Flunitrazepam—Diplopia—Capecitabine—esophageal cancer	1.79e-05	0.0212	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—CA2—esophageal cancer	1.78e-05	8.38e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.76e-05	8.27e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.75e-05	8.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.74e-05	8.2e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.74e-05	8.19e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.71e-05	8.03e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.71e-05	8.02e-05	CbGpPWpGaD
Flunitrazepam—Irritability—Capecitabine—esophageal cancer	1.7e-05	0.0202	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.7e-05	8.01e-05	CbGpPWpGaD
Flunitrazepam—Ataxia—Capecitabine—esophageal cancer	1.68e-05	0.0199	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.67e-05	7.87e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NOS3—esophageal cancer	1.67e-05	7.83e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.66e-05	7.8e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADH7—esophageal cancer	1.66e-05	7.8e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GNG7—esophageal cancer	1.66e-05	7.79e-05	CbGpPWpGaD
Flunitrazepam—Orthostatic hypotension—Capecitabine—esophageal cancer	1.63e-05	0.0193	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.63e-05	7.65e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TPI1—esophageal cancer	1.63e-05	7.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.62e-05	7.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.61e-05	7.55e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.6e-05	7.53e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.6e-05	7.5e-05	CbGpPWpGaD
Flunitrazepam—Muscular weakness—Capecitabine—esophageal cancer	1.57e-05	0.0187	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.57e-05	7.4e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.56e-05	7.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.55e-05	7.3e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—esophageal cancer	1.52e-05	7.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ENO1—esophageal cancer	1.52e-05	7.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.52e-05	7.14e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CREBBP—esophageal cancer	1.51e-05	7.11e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.5e-05	7.06e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PSME1—esophageal cancer	1.5e-05	7.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PSME2—esophageal cancer	1.5e-05	7.03e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—EP300—esophageal cancer	1.49e-05	7.01e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.49e-05	7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.48e-05	6.95e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.47e-05	6.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.46e-05	6.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.46e-05	6.84e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.45e-05	6.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.44e-05	6.75e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GNG7—esophageal cancer	1.42e-05	6.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.41e-05	6.61e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TYMP—esophageal cancer	1.39e-05	6.53e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ENO1—esophageal cancer	1.38e-05	6.51e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.38e-05	6.51e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.38e-05	6.48e-05	CbGpPWpGaD
Flunitrazepam—Tremor—Cisplatin—esophageal cancer	1.37e-05	0.0162	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—PSME1—esophageal cancer	1.36e-05	6.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PSME2—esophageal cancer	1.36e-05	6.41e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NOS3—esophageal cancer	1.35e-05	6.36e-05	CbGpPWpGaD
Flunitrazepam—Ill-defined disorder—Cisplatin—esophageal cancer	1.35e-05	0.016	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.35e-05	6.35e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.33e-05	6.24e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.32e-05	6.19e-05	CbGpPWpGaD
Flunitrazepam—Malaise—Cisplatin—esophageal cancer	1.32e-05	0.0156	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.31e-05	6.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.29e-05	6.07e-05	CbGpPWpGaD
Flunitrazepam—Irritability—Methotrexate—esophageal cancer	1.27e-05	0.015	CcSEcCtD
Flunitrazepam—UGT2B7—Metabolism—EP300—esophageal cancer	1.27e-05	5.96e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.26e-05	5.94e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.26e-05	5.91e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TPI1—esophageal cancer	1.26e-05	5.91e-05	CbGpPWpGaD
Flunitrazepam—Ataxia—Methotrexate—esophageal cancer	1.25e-05	0.0148	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.25e-05	5.87e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.24e-05	5.84e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—esophageal cancer	1.24e-05	5.82e-05	CbGpPWpGaD
Flunitrazepam—Anxiety—Cisplatin—esophageal cancer	1.24e-05	0.0147	CcSEcCtD
Flunitrazepam—Discomfort—Cisplatin—esophageal cancer	1.23e-05	0.0145	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.21e-05	5.71e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.21e-05	5.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.19e-05	5.6e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ENO1—esophageal cancer	1.18e-05	5.56e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.18e-05	5.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.18e-05	5.53e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PSME1—esophageal cancer	1.17e-05	5.48e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PSME2—esophageal cancer	1.17e-05	5.48e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.17e-05	5.48e-05	CbGpPWpGaD
Flunitrazepam—Tachycardia—Cisplatin—esophageal cancer	1.16e-05	0.0138	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.16e-05	5.45e-05	CbGpPWpGaD
Flunitrazepam—Hyperhidrosis—Cisplatin—esophageal cancer	1.15e-05	0.0136	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.15e-05	5.4e-05	CbGpPWpGaD
Flunitrazepam—Hypotension—Cisplatin—esophageal cancer	1.11e-05	0.0132	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.11e-05	5.21e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.11e-05	5.2e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—esophageal cancer	1.1e-05	5.18e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GNG7—esophageal cancer	1.09e-05	5.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.09e-05	5.11e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.06e-05	5e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NOS3—esophageal cancer	1.04e-05	4.91e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—EP300—esophageal cancer	1.03e-05	4.84e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.02e-05	4.82e-05	CbGpPWpGaD
Flunitrazepam—Drowsiness—Methotrexate—esophageal cancer	1.02e-05	0.0121	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.02e-05	4.79e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.01e-05	4.75e-05	CbGpPWpGaD
Flunitrazepam—Tremor—Capecitabine—esophageal cancer	1.01e-05	0.0119	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.01e-05	4.73e-05	CbGpPWpGaD
Flunitrazepam—Ill-defined disorder—Capecitabine—esophageal cancer	9.98e-06	0.0118	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.91e-06	4.66e-05	CbGpPWpGaD
Flunitrazepam—Sweating—Methotrexate—esophageal cancer	9.82e-06	0.0116	CcSEcCtD
Flunitrazepam—Feeling abnormal—Cisplatin—esophageal cancer	9.81e-06	0.0116	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—GSTT1—esophageal cancer	9.75e-06	4.58e-05	CbGpPWpGaD
Flunitrazepam—Malaise—Capecitabine—esophageal cancer	9.7e-06	0.0115	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—ABCB1—esophageal cancer	9.7e-06	4.56e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	9.63e-06	4.53e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—esophageal cancer	9.55e-06	4.49e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP19A1—esophageal cancer	9.46e-06	4.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CREBBP—esophageal cancer	9.41e-06	4.42e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—esophageal cancer	9.38e-06	4.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CREBBP—esophageal cancer	9.21e-06	4.33e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ENO1—esophageal cancer	9.13e-06	4.29e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS1—esophageal cancer	9.13e-06	4.29e-05	CbGpPWpGaD
Flunitrazepam—Anxiety—Capecitabine—esophageal cancer	9.12e-06	0.0108	CcSEcCtD
Flunitrazepam—Discomfort—Capecitabine—esophageal cancer	9.05e-06	0.0107	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—PSME2—esophageal cancer	9e-06	4.23e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PSME1—esophageal cancer	9e-06	4.23e-05	CbGpPWpGaD
Flunitrazepam—Dry mouth—Capecitabine—esophageal cancer	8.95e-06	0.0106	CcSEcCtD
Flunitrazepam—Confusional state—Capecitabine—esophageal cancer	8.85e-06	0.0105	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—HMOX1—esophageal cancer	8.63e-06	4.06e-05	CbGpPWpGaD
Flunitrazepam—Tachycardia—Capecitabine—esophageal cancer	8.57e-06	0.0102	CcSEcCtD
Flunitrazepam—Asthenia—Cisplatin—esophageal cancer	8.54e-06	0.0101	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Capecitabine—esophageal cancer	8.48e-06	0.0101	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.47e-06	3.98e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NOS3—esophageal cancer	8.42e-06	3.96e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCB1—esophageal cancer	8.29e-06	3.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NOS3—esophageal cancer	8.25e-06	3.88e-05	CbGpPWpGaD
Flunitrazepam—Hypotension—Capecitabine—esophageal cancer	8.2e-06	0.00972	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.04e-06	3.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—EP300—esophageal cancer	7.94e-06	3.73e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.77e-06	3.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—esophageal cancer	7.7e-06	3.62e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—esophageal cancer	7.62e-06	3.58e-05	CbGpPWpGaD
Flunitrazepam—Fatigue—Capecitabine—esophageal cancer	7.57e-06	0.00897	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—esophageal cancer	7.54e-06	3.55e-05	CbGpPWpGaD
Flunitrazepam—Rash—Cisplatin—esophageal cancer	7.51e-06	0.0089	CcSEcCtD
Flunitrazepam—Dermatitis—Cisplatin—esophageal cancer	7.5e-06	0.00889	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Methotrexate—esophageal cancer	7.43e-06	0.00881	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.33e-06	3.45e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.3e-06	3.43e-05	CbGpPWpGaD
Flunitrazepam—Feeling abnormal—Capecitabine—esophageal cancer	7.23e-06	0.00857	CcSEcCtD
Flunitrazepam—Malaise—Methotrexate—esophageal cancer	7.22e-06	0.00856	CcSEcCtD
Flunitrazepam—CYP2C19—Metabolism—CREBBP—esophageal cancer	7.11e-06	3.34e-05	CbGpPWpGaD
Flunitrazepam—Discomfort—Methotrexate—esophageal cancer	6.73e-06	0.00798	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.66e-06	3.13e-05	CbGpPWpGaD
Flunitrazepam—Confusional state—Methotrexate—esophageal cancer	6.59e-06	0.00781	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.48e-06	3.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—EP300—esophageal cancer	6.41e-06	3.01e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.4e-06	3.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NOS3—esophageal cancer	6.36e-06	2.99e-05	CbGpPWpGaD
Flunitrazepam—Hyperhidrosis—Methotrexate—esophageal cancer	6.32e-06	0.00749	CcSEcCtD
Flunitrazepam—Asthenia—Capecitabine—esophageal cancer	6.3e-06	0.00747	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—EP300—esophageal cancer	6.27e-06	2.95e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.27e-06	2.94e-05	CbGpPWpGaD
Flunitrazepam—Hypotension—Methotrexate—esophageal cancer	6.11e-06	0.00724	CcSEcCtD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—esophageal cancer	5.87e-06	2.76e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.82e-06	2.74e-05	CbGpPWpGaD
Flunitrazepam—Somnolence—Methotrexate—esophageal cancer	5.81e-06	0.00689	CcSEcCtD
Flunitrazepam—Dizziness—Capecitabine—esophageal cancer	5.8e-06	0.00688	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—NOS3—esophageal cancer	5.8e-06	2.73e-05	CbGpPWpGaD
Flunitrazepam—Fatigue—Methotrexate—esophageal cancer	5.63e-06	0.00668	CcSEcCtD
Flunitrazepam—CYP1A2—Metabolism—CREBBP—esophageal cancer	5.54e-06	2.6e-05	CbGpPWpGaD
Flunitrazepam—Rash—Capecitabine—esophageal cancer	5.53e-06	0.00656	CcSEcCtD
Flunitrazepam—Dermatitis—Capecitabine—esophageal cancer	5.53e-06	0.00655	CcSEcCtD
Flunitrazepam—Headache—Capecitabine—esophageal cancer	5.5e-06	0.00652	CcSEcCtD
Flunitrazepam—Feeling abnormal—Methotrexate—esophageal cancer	5.38e-06	0.00638	CcSEcCtD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.31e-06	2.49e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NOS3—esophageal cancer	4.96e-06	2.33e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—EP300—esophageal cancer	4.84e-06	2.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—esophageal cancer	4.74e-06	2.23e-05	CbGpPWpGaD
Flunitrazepam—Asthenia—Methotrexate—esophageal cancer	4.69e-06	0.00556	CcSEcCtD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—esophageal cancer	4.64e-06	2.18e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.54e-06	2.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—EP300—esophageal cancer	4.41e-06	2.07e-05	CbGpPWpGaD
Flunitrazepam—Dizziness—Methotrexate—esophageal cancer	4.32e-06	0.00512	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.27e-06	2.01e-05	CbGpPWpGaD
Flunitrazepam—Rash—Methotrexate—esophageal cancer	4.12e-06	0.00488	CcSEcCtD
Flunitrazepam—Dermatitis—Methotrexate—esophageal cancer	4.12e-06	0.00488	CcSEcCtD
Flunitrazepam—Headache—Methotrexate—esophageal cancer	4.09e-06	0.00485	CcSEcCtD
Flunitrazepam—CYP3A4—Metabolism—NOS3—esophageal cancer	3.83e-06	1.8e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—EP300—esophageal cancer	3.77e-06	1.77e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.58e-06	1.68e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.5e-06	1.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.27e-06	1.53e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—EP300—esophageal cancer	2.91e-06	1.37e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.79e-06	1.31e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.15e-06	1.01e-05	CbGpPWpGaD
